HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. The internal probe is with regards to whether or not the incentives that were meant to be used to promote the dental supplier’s products were properly accounted for. Despite the hasty departure, Gomez will receive his pay for the entire year.

CFO 52

CFO Chief Financial Officer Due Diligence Biotechnology 52

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 1, 2012

For example, in biotechnology, a field in which the U.S. First, that means tax incentives. But in order to translate these advantages into jobs, America must focus its incentives on supporting companies that make products under contract to other firms and excel in process and incremental innovation.

Contract Manufacturing 9

Contract Manufacturing Offshoring Supply Chain Biotechnology 9

Harvard Business Review

AUGUST 17, 2015

If you invest in human capital, whether in your company or in your country, sooner or later it will pay off if you have the right set of incentives. It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. That’s what Cuba doesn’t have.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. At NPS, the values evaluation and rating has a direct and significant impact on salary increases and both short- and long-term incentives.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

JUNE 16, 2016

” That’s really essential, because the different players often have widely divergent incentives. . “But here, we can operate within the time frame of the next coffee break.”

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

MARCH 17, 2014

Hospitals, parks, educational systems, sanitation infrastructure, low-income housing — globally, risk-seeking investors build these solutions in partnership with the public sector, which plays its part to adjust incentives, act as a major customer, and provide subsidy where needed. Surely we can do the same for impact investing.

Development 8

Development Microfinance Biotechnology Exit Strategy 8